Transmission dynamics of ESBL/AmpC and carbapenemase-producing Enterobacterales between companion animals and humans.
CMY-2
CTX-M-15 ESBL
CTX-M-27
Enterobacter hormaechei subsp. hoffmannii
ExPEC pathotypes
Klebsiella pneumoniae
animal–human sharing
one health
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2024
2024
Historique:
received:
13
05
2024
accepted:
05
08
2024
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
18
9
2024
Statut:
epublish
Résumé
Antimicrobial resistance mediated by extended-spectrum beta-lactamase (ESBL)- and plasmid-mediated cephalosporinase (AmpC)-producing Enterobacterales, as well as carbapenemase-producing Enterobacterales have globally increased among companion animals, posing a potential health risk to humans in contact with them. This prospective longitudinal study investigates the transfer of ESBL/AmpC- and carbapenemase-producing Enterobacterales between companion animals and their cohabitant humans in Portugal (PT) and the United Kingdom (UK) during animal infection. Fecal samples and nasal swabs collected from dogs and cats with urinary tract infection (UTI) or skin and soft tissue infection (SSTI), and their cohabitant humans were screened for resistant strains. Relatedness between animal and human strains was established by whole-genome sequencing (WGS). ESBL/AmpC-producing Enterobacterales were detected in companion animals (PT = 55.8%; UK = 36.4%) and humans (PT = 35.9%; UK = 12.5%). Carbapenemase-producing Enterobacterales carriage was observed in one dog from Portugal (2.6%) and another dog from the UK (4.5%). Transmission of index clinical ESBL-producing
Identifiants
pubmed: 39290515
doi: 10.3389/fmicb.2024.1432240
pmc: PMC11405340
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1432240Informations de copyright
Copyright © 2024 Menezes, Frosini, Weese, Perreten, Schwarz, Amaral, Loeffler and Pomba.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.